HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Conservative loco-regional treatment of soft tissue sarcoma in adults after induction chemotherapy].

Abstract
Between June, 1979 and December, 1983, 23 adult patients with non-metastatic soft tissue sarcoma were treated with induction chemotherapy since local spread precluded primary conservative surgery. Eighteen patients received a combined cyclophosphamide, vincristine, adriamycin and dacarbazine treatment and 5, a combined adriamycin, cis-platinum and vindesine treatment. Both drug combinations exhibited toxic effects, notably on blood and digestive tract. However, tumoral volume was reduced by 50 p. cent or more in 14/23 patients, including 2 complete remissions; the course of the disease remained unchanged under treatment in only 3 cases. Chemotherapy facilitated surgical excision in 14 patients, and subsequent radiotherapy resulted in complete remission in 13 of these. None of the 13 patients relapsed during a mean follow-up period of 12 months (range: 3 to 48 months). Among the 9 patients who could not be operated upon, 5 benefited from radiotherapy with satisfactory local control, but only one still remains in complete remission. Thus, induction chemotherapy made it possible to achieve local control in two-thirds of patients with locally advanced sarcoma. However, a more prolonged follow-up is necessary to confirm that these results are long-lasting and to determine the effects of chemotherapy, if any, on the metastatic potential of these tumours.
AuthorsD Marée, C Hocke, N B Bui, J M Coindre, P Tramond, A Avril, P Mage, J Chauvergne, P Richaud
JournalPresse medicale (Paris, France : 1983) (Presse Med) Vol. 14 Issue 19 Pg. 1069-72 (May 11 1985) ISSN: 0755-4982 [Print] France
Vernacular TitleTraitement loco-régional conservateur des sarcomes des tissus mous chez l'adulte après chimiothérapie d'induction.
PMID3158961 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Vincristine
  • Vinblastine
  • Dacarbazine
  • Doxorubicin
  • Cyclophosphamide
  • Cisplatin
  • Vindesine
Topics
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols (adverse effects, therapeutic use)
  • Cisplatin (administration & dosage)
  • Combined Modality Therapy
  • Cyclophosphamide (administration & dosage)
  • Dacarbazine (administration & dosage)
  • Doxorubicin (administration & dosage)
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Sarcoma (drug therapy, radiotherapy, surgery)
  • Soft Tissue Neoplasms (drug therapy, radiotherapy, surgery)
  • Vinblastine (administration & dosage, analogs & derivatives)
  • Vincristine (administration & dosage)
  • Vindesine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: